Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise Training in Treating Diastolic Heart Failure
NCT02155842
Efficacy of a Home-Based Exercise Program for Heart Failure
NCT01407185
HEARTS: Heart, Exercise, and Resistance Training Study
NCT00094250
Prospective Aerobic Reconditioning Intervention Study
NCT01113840
Identifying Markers of Exercise Training in Heart Failure
NCT05696652
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
heart failure
aerobic exercise training
aerobic exercise training
12 weeks of supervised aerobic exercise training
heart failure plus type 2 diabetes
aerobic exercise training
aerobic exercise training
12 weeks of supervised aerobic exercise training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
aerobic exercise training
12 weeks of supervised aerobic exercise training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* New York Heart Association class II-III CHF and ejection fraction ≤35%
* receiving optimal medical therapy
* sedentary (≤ 30 min/wk structured physical activity).
* Half of volunteers (n=30) will have a diagnosis of type 2 diabetes (CHF+T2D).
Exclusion Criteria
* changes in medication ≤6 wk prior to enrollment
* major cardiovascular event or procedure ≤6 wk prior to enrollment
* foot ulcers
* advanced neuropathy
* co-morbidities or other limitations that may interfere with or prevent volunteers from safely completing the exercise training
* fixed rate pacemaker
* type 1 diabetes mellitus
50 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Kraus, MD
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke University Medical Center
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00032063
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.